trial
as of 2026-07-01PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia
NCTId NCT05839613
at a glance
— · Not Yet Recruiting
Enrollment 400 (estimated)
Sponsored by Assistance Publique Hopitaux De Marseille
Primary completion 2027-05
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Not Yet Recruiting
Enrollment
400 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2023-05
Primary completion
2027-05
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
Assistance Publique Hopitaux De MarseilleLead Sponsor
Sites
0 total
Facts & assertions
4 sourced
Enrollment
400
Phase
NA
Primary Completion Date
2027-05
Status
NOT_YET_RECRUITING
relationships
The graph out of here
lead_sponsor
indication
indication